Skip to main content

Animations

MJFF Publications

4441 - 4450 of 6516 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003
    Citation Count: 11
  • Summary Details
    OPEN
    Title: North American survey on impact of the COVID-19 pandemic shutdown on DBS care
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Preoperative Evaluation of Parkinson’s Disease
    Journal Name: Cureus
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7759/cureus.15933
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy
    Journal Name: Acta Pharmaceutica Sinica B
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.apsb.2021.06.007
    Citation Count: 58
  • Summary Details
    OPEN
    Title: A conversation with Judith Campisi: Leader in the field of aging research
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
    Journal Name: Analytica Chimica Acta
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.aca.2021.338259
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Tau induces formation of α-synuclein filaments with distinct molecular conformations
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2021.03.091
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Data imputation and compression for Parkinson's disease clinical questionnaires
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051
    Citation Count: 30
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.